What is Everest Re Gp's earnings per share (EPS)?

Everest Re Gp (EG) reported diluted earnings per share of $37.80 for fiscal year 2025. This represents a 18.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Everest Re Gp Financials

Trailing 12 months to June 30, 2026

Revenue $16.8B -5.1% YoY

Net Income $1.9B +137.3% YoY

EPS (Diluted) $47.26 +146.4% YoY

Free Cash Flow Not reported for the trailing 12 months

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 3, 2026 Currency USD FYE December

Everest Re Gp (EG) reported $16.8B in revenue over the twelve months to Jun 30, 2026, down 5.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI EG FY2025 2026-08-29

Balance-sheet expansion is absorbing revenue growth, while earnings remain more volatile than operating cash generation across FY2023-FY2025.

From FY2023 to FY2025, revenue growth reached 20.0% while operating cash flow fell 32.6%, showing that a larger top line did not translate proportionally into cash. Yet FY2025 operating cash flow was 1.9x net income, making cash conversion more resilient than the earnings trend alone suggests.

The asset base expanded 11.0% in FY2025 while revenue increased only 1.2%, pointing to a capital base growing faster than current top-line absorption. Liabilities and equity both rose about 11.0%, leaving debt-to-equity nearly unchanged at 3.0x; leverage is elevated, but the latest expansion did not materially shift financing toward debt.

The 2025 financing outflow coincided with $797M of buybacks and $335M of dividends, making shareholder distributions a visible use of cash. Because free cash flow and capital expenditures are not reported, the tables support identifying that cash use, not judging whether reinvestment fully funded it.

Financial Health Signals

Financial Health Score 38/100

Scored as: Insurers peer group

Scored against insurers for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Everest Re Gp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Loss Ratio

Premium Growth

Capital

Investment Yield

Not available for Everest Re Gp, and counted as zero in the overall score.

Combined Ratio

Stability

Piotroski F-Score Partial

5/6

Everest Re Gp passes 5 of 6 computable financial strength tests (3 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 1 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.93x

For every $1 of reported earnings, Everest Re Gp generates $1.93 in operating cash flow ($3.1B OCF vs $1.6B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$17.5B

YoY+1.2%

5Y CAGR+12.8%

10Y CAGR+11.9%

Everest Re Gp generated $17.5B in revenue in fiscal year 2025. This represents an increase of 1.2% from the prior year.

Net Income

$1.6B

YoY+15.9%

5Y CAGR+25.4%

10Y CAGR+5.0%

Everest Re Gp reported $1.6B in net income in fiscal year 2025. This represents an increase of 15.9% from the prior year.

EPS (Diluted)

$37.80

YoY+18.9%

5Y CAGR+24.2%

10Y CAGR+5.5%

Everest Re Gp earned $37.80 per diluted share (EPS) in fiscal year 2025. This represents an increase of 18.9% from the prior year.

EBITDA

Not reported for fiscal year 2025.

Cash & Balance Sheet

Cash & Debt

$1.3B

YoY-14.9%

5Y CAGR+10.4%

10Y CAGR+16.6%

Everest Re Gp held $1.3B in cash as of fiscal year 2025; long-term debt is not reported for that period.

Dividends Per Share

$8.00

YoY+3.2%

5Y CAGR+5.2%

10Y CAGR+7.2%

Everest Re Gp paid $8.00 per share in dividends in fiscal year 2025. This represents an increase of 3.2% from the prior year.

Shares Outstanding

40M

YoY-5.9%

5Y CAGR+0.2%

10Y CAGR-0.6%

Everest Re Gp had 40M shares outstanding in fiscal year 2025. This represents a decrease of 5.9% from the prior year.

Free Cash Flow

Not reported for fiscal year 2025.

Margins & Returns

Net Margin

9.1%

YoY+1.1pp

5Y CAGR+3.7pp

10Y CAGR-8.1pp

Everest Re Gp's net profit margin was 9.1% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1.1 percentage points from the prior year.

Return on Equity

10.3%

YoY+0.4pp

5Y CAGR+5.0pp

10Y CAGR-2.6pp

Everest Re Gp's ROE was 10.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 0.4 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Operating Margin

Not reported for fiscal year 2025.

Capital Allocation

Share Buybacks

$797.0M

YoY+298.5%

5Y CAGR+31.9%

10Y CAGR+7.1%

Everest Re Gp spent $797.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 298.5% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

Capital Expenditures

Not reported for fiscal year 2025.

EG Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

EG quarterly income statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	$16.8B	$17.5B+1.2%	$17.3B+18.5%	$14.6B+21.0%	$12.1B+1.6%	$11.9B+23.6%	$9.6B+16.6%	$8.2B+11.8%	$7.4B+11.2%	$6.6B+14.3%	$5.8B+2.1%	$5.7B0.0%	$5.7B+0.7%	$5.6B+14.6%	$4.9B+4.9%	$4.7B
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$23.3M-0.7%	$23.4M-5.6%	$24.8M+3.5%	$24.0M+45.7%	$16.5M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$31.7M+2.1%	$31.0M-1.8%	$31.6M-12.8%	$36.2M+0.1%	$36.2M-6.1%	$38.5M-16.4%	$46.1M-14.1%	$53.7M+2.6%	$52.3M
Income Tax	$329.0M	$296.0M+146.7%	$120.0M+133.1%	-$363.0M-3933.3%	-$9.0M-105.4%	$167.0M+135.2%	$71.0M-20.7%	$89.5M+127.0%	-$331.2M-422.9%	-$63.3M-161.2%	$103.5M-22.8%	$134.0M-28.6%	$187.7M-35.2%	$289.7M+162.0%	$110.6M+172.1%	-$153.5M
Net Income	$1.9B	$1.6B+15.9%	$1.4B-45.5%	$2.5B+321.6%	$597.0M-56.7%	$1.4B+168.3%	$514.0M-49.1%	$1.0B+1033.7%	$89.0M-81.6%	$482.8M-51.5%	$996.3M+1.9%	$977.9M-18.5%	$1.2B-4.8%	$1.3B+51.9%	$829.0M+1129.9%	-$80.5M
EPS (Diluted)	$47.26	$37.80+18.9%	$31.78-47.2%	$60.19+296.2%	$15.19-56.1%	$34.62+170.9%	$12.78-48.3%	$24.70+1038.2%	$2.17-81.5%	$11.70-50.6%	$23.68+7.1%	$22.10-14.7%	$25.91+1.8%	$25.44+61.1%	$15.79+1159.7%	-$1.49

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$4.0B-2.6%	$4.1B-8.0%	$4.4B+2.4%	$4.3B-3.8%	$4.5B+5.3%	$4.3B-8.0%	$4.6B+8.2%	$4.3B
Income Tax	$124.0M+49.4%	$83.0M-23.1%	$108.0M+671.4%	$14.0M-89.6%	$135.0M+246.2%	$39.0M+125.2%	-$155.0M-327.9%	$68.0M
Net Income	$559.0M-14.4%	$653.0M+46.4%	$446.0M+74.9%	$255.0M-62.5%	$680.0M+223.8%	$210.0M+135.4%	-$593.0M-216.5%	$509.0M
EPS (Diluted)	$14.22-12.3%	$16.21+50.9%	$10.74+76.4%	$6.09-62.2%	$16.10+228.6%	$4.90+136.0%	-$13.62-215.4%	$11.80

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, Interest Expense.

EG Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

EG quarterly balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$62.5B+11.0%	$56.3B+14.1%	$49.4B+23.6%	$40.0B+4.7%	$38.2B+16.7%	$32.7B+19.7%	$27.3B+10.4%	$24.8B+5.0%	$23.6B+10.5%	$21.3B+3.8%	$20.6B-1.3%	$20.8B+5.1%	$19.8B+0.2%	$19.8B+4.7%	$18.9B
Cash & Equivalents	$1.3B-14.9%	$1.5B+7.8%	$1.4B+2.8%	$1.4B-3.0%	$1.4B+79.7%	$802.0M-0.7%	$808.0M+23.2%	$656.1M+3.3%	$635.1M+31.8%	$481.9M+69.9%	$283.7M-35.2%	$437.5M-28.4%	$611.4M+13.8%	$537.0M+19.7%	$448.7M
Total Liabilities	$47.1B+10.8%	$42.5B+17.3%	$36.2B+14.8%	$31.5B+12.4%	$28.0B+22.0%	$23.0B+26.4%	$18.2B+7.7%	$16.9B+11.0%	$15.2B+14.9%	$13.2B+2.3%	$12.9B0.0%	$12.9B+1.6%	$12.7B-2.3%	$13.0B+1.7%	$12.8B
Total Equity	$15.5B+11.4%	$13.9B+5.1%	$13.2B+56.4%	$8.4B-16.7%	$10.1B+4.2%	$9.7B+6.5%	$9.1B+16.2%	$7.9B-5.8%	$8.3B+3.3%	$8.1B+6.1%	$7.6B+2.1%	$7.5B+6.9%	$7.0B+3.5%	$6.7B+10.9%	$6.1B
Retained Earnings	$16.6B+8.2%	$15.3B+7.3%	$14.3B+18.5%	$12.0B+2.9%	$11.7B+10.7%	$10.6B+2.5%	$10.3B+8.1%	$9.5B-1.3%	$9.7B+2.5%	$9.4B+9.3%	$8.6B+10.3%	$7.8B+15.6%	$6.8B+20.5%	$5.6B+14.9%	$4.9B

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$62.2B-0.3%	$62.3B-0.3%	$62.5B+0.4%	$62.2B+2.8%	$60.5B+4.1%	$58.1B+3.2%	$56.3B+0.9%	$55.9B
Cash & Equivalents	$1.1B-21.1%	$1.4B+7.4%	$1.3B-14.4%	$1.5B-19.1%	$1.9B+21.4%	$1.6B+1.2%	$1.5B-3.1%	$1.6B
Total Liabilities	$46.7B-0.7%	$47.1B0.0%	$47.1B+0.4%	$46.9B+3.0%	$45.5B+3.4%	$44.0B+3.6%	$42.5B+4.8%	$40.5B
Total Equity	$15.4B+0.9%	$15.3B-1.1%	$15.5B+0.6%	$15.4B+2.4%	$15.0B+6.2%	$14.1B+1.9%	$13.9B-9.5%	$15.3B
Retained Earnings	$17.6B+2.8%	$17.1B+3.5%	$16.6B+2.2%	$16.2B+1.1%	$16.0B+3.9%	$15.4B+0.8%	$15.3B-4.2%	$16.0B

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Goodwill, Current Liabilities, Long-Term Debt.

EG Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

EG quarterly cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	$2.0B	$3.1B-38.1%	$5.0B+8.9%	$4.6B+23.2%	$3.7B-3.6%	$3.8B+33.4%	$2.9B+55.2%	$1.9B+203.6%	$610.1M-47.5%	$1.2B-16.0%	$1.4B+24.8%	$1.1B+5.1%	$1.1B-4.0%	$1.1B+65.4%	$663.9M+0.7%	$659.5M
Investing Cash Flow	-$1.3B	-$2.1B+53.2%	-$4.5B+24.1%	-$5.9B-72.7%	-$3.4B+11.7%	-$3.9B-5.1%	-$3.7B-160.7%	-$1.4B-405.1%	-$279.6M+61.8%	-$732.6M-11.4%	-$657.9M+3.4%	-$681.1M	N/A	N/A	-$233.8M-12.0%	-$208.7M
Financing Cash Flow	-$1.5B	-$1.2B-206.8%	-$383.0M-127.2%	$1.4B+492.5%	-$359.0M-153.3%	$674.0M-15.8%	$800.0M+390.2%	-$275.7M+12.9%	-$316.6M-14.9%	-$275.5M+52.6%	-$581.5M-1.5%	-$573.2M	N/A	N/A	-$368.9M-57.6%	-$234.1M
Dividends Paid	$324.0M	$335.0M+0.3%	$334.0M+16.0%	$288.0M+12.9%	$255.0M+3.2%	$247.0M-0.8%	$249.0M+6.3%	$234.3M+8.4%	$216.2M+4.3%	$207.2M+6.1%	$195.4M+11.6%	$175.1M+20.0%	$145.9M+36.8%	$106.7M+6.3%	$100.4M-3.3%	$103.8M
Share Buybacks	$1.1B	$797.0M+298.5%	$200.0M	$0-100.0%	$61.0M-72.9%	$225.0M+12.5%	$200.0M+712.9%	$24.6M-67.3%	$75.3M+50.6%	$50.0M-87.1%	$386.3M-3.4%	$400.1M-20.0%	$500.0M-19.6%	$621.9M+114.5%	$290.0M+213.5%	$92.5M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	$290.0M-55.3%	$649.0M+263.1%	-$398.0M-127.3%	$1.5B+35.2%	$1.1B+16.3%	$928.0M+19.0%	$780.0M-55.1%	$1.7B
Investing Cash Flow	-$111.0M-26.1%	-$88.0M-113.3%	$663.0M+138.0%	-$1.7B-292.1%	-$445.0M+21.8%	-$569.0M+39.0%	-$933.0M+39.0%	-$1.5B
Financing Cash Flow	-$473.0M-4.2%	-$454.0M+5.8%	-$482.0M-467.1%	-$85.0M+70.1%	-$284.0M+12.3%	-$324.0M-389.3%	$112.0M+158.9%	-$190.0M
Dividends Paid	$78.0M-2.5%	$80.0M-2.4%	$82.0M-2.4%	$84.0M0.0%	$84.0M-1.2%	$85.0M0.0%	$85.0M-1.2%	$86.0M
Share Buybacks	$395.0M+19.7%	$330.0M-16.9%	$397.0M	$0-100.0%	$200.0M0.0%	$200.0M	$0-100.0%	$100.0M

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow.

EG Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

EG quarterly financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Net Margin	9.1%+1.1pp	8.0%-9.3pp	17.3%+12.3pp	5.0%-6.7pp	11.6%+6.3pp	5.4%-6.9pp	12.3%+11.1pp	1.2%-6.1pp	7.3%-9.9pp	17.2%0.0pp	17.2%-3.9pp	21.1%-1.2pp	22.3%+5.5pp	16.8%+18.6pp	-1.7%
Return on Equity	10.3%+0.4pp	9.9%-9.2pp	19.1%+12.0pp	7.1%-6.5pp	13.6%+8.3pp	5.3%-5.8pp	11.1%+9.9pp	1.1%-4.7pp	5.8%-6.6pp	12.3%-0.5pp	12.8%-3.2pp	16.1%-2.0pp	18.1%+5.8pp	12.3%+13.6pp	-1.3%
Return on Assets	2.5%+0.1pp	2.4%-2.7pp	5.1%+3.6pp	1.5%-2.1pp	3.6%+2.0pp	1.6%-2.1pp	3.7%+3.3pp	0.4%-1.7pp	2.1%-2.6pp	4.7%-0.1pp	4.8%-1.0pp	5.8%-0.6pp	6.4%+2.2pp	4.2%+4.6pp	-0.4%
Debt-to-Equity	3.040.0x	3.06+0.3x	2.74-1.0x	3.73+1.0x	2.77+0.4x	2.36+0.4x	1.99-0.2x	2.15+0.3x	1.83+0.2x	1.64-0.1x	1.700.0x	1.74-0.1x	1.83-0.1x	1.94-0.2x	2.11

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Net Margin	14.1%-1.9pp	16.1%+6.0pp	10.1%+4.2pp	5.9%-9.2pp	15.1%+10.2pp	4.9%+17.7pp	-12.8%-24.7pp	11.9%
Return on Equity	3.6%-0.6pp	4.3%+1.4pp	2.9%+1.2pp	1.7%-2.9pp	4.5%+3.0pp	1.5%+5.8pp	-4.3%-7.6pp	3.3%
Return on Assets	0.9%-0.2pp	1.1%+0.3pp	0.7%+0.3pp	0.4%-0.7pp	1.1%+0.8pp	0.4%+1.4pp	-1.1%-2.0pp	0.9%
Debt-to-Equity	3.030.0x	3.080.0x	3.040.0x	3.050.0x	3.03-0.1x	3.11+0.1x	3.06+0.4x	2.64

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.

Similar Companies

Reinsurance Grp RGA

$16.0B

Renaissance RNR

$13.7B

Hamilton Insurance Group HG

$3.5B

Siriuspoint Ltd SPNT

$2.8B

Ryan Specialty Hldgs Inc RYAN

$11.2B

Where Everest Re Gp Ranks

Frequently Asked Questions

What is Everest Re Gp's annual revenue?

Everest Re Gp (EG) reported $17.5B in total revenue for fiscal year 2025. This represents a 1.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Everest Re Gp's revenue growing?

Everest Re Gp (EG) revenue grew by 1.2% year-over-year, from $17.3B to $17.5B in fiscal year 2025.

Is Everest Re Gp profitable?

Yes, Everest Re Gp (EG) reported a net income of $1.6B in fiscal year 2025, with a net profit margin of 9.1%.

What is Everest Re Gp's net profit margin?

Everest Re Gp (EG) had a net profit margin of 9.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Everest Re Gp pay dividends?

Yes, Everest Re Gp (EG) paid $8.00 per share in dividends during fiscal year 2025.

What is Everest Re Gp's return on equity (ROE)?

Everest Re Gp (EG) has a return on equity of 10.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Everest Re Gp's operating cash flow?

Everest Re Gp (EG) generated $3.1B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Everest Re Gp's total assets?

Everest Re Gp (EG) had $62.5B in total assets as of fiscal year 2025, including both current and long-term assets.

Does Everest Re Gp buy back shares?

Yes, Everest Re Gp (EG) spent $797.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Everest Re Gp have outstanding?

Everest Re Gp (EG) had 40M shares outstanding as of fiscal year 2025.

What is Everest Re Gp's debt-to-equity ratio?

Everest Re Gp (EG) had a debt-to-equity ratio of 3.04 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Everest Re Gp's return on assets (ROA)?

Everest Re Gp (EG) had a return on assets of 2.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Everest Re Gp's Piotroski F-Score?

Everest Re Gp (EG) has a Piotroski F-Score of 5 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Everest Re Gp's earnings high quality?

Everest Re Gp (EG) has an earnings quality ratio of 1.93x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Everest Re Gp?

Everest Re Gp (EG) scores 38 out of 100 on our Financial Health Score, indicating weak standing within its insurers peer group. The score is a 0-100 composite of six dimensions (Loss Ratio, Premium Growth, Capital, Investment Yield, Combined Ratio, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.